IGF1-LR3 Research Overview
IGF1-LR3 Pharmaqo is an extended analogue of insulin-like growth factor-1 (IGF-1) engineered for enhanced stability and bioavailability in research applications. This modified peptide features substitutions at position 3 and an N-terminal extension that significantly reduce binding to IGF-binding proteins, resulting in extended biological activity compared to native IGF-1. The LR3 variant demonstrates improved resistance to proteolytic degradation in laboratory conditions, making it particularly valuable for extended in-vitro studies. Researchers at Stroid UK Shop frequently investigate this peptide’s unique pharmacokinetic properties in cellular models.
Laboratory Research Applications
Scientists examine IGF1-LR3 in various research contexts, particularly focusing on cellular proliferation, differentiation, and metabolic pathway analysis. The peptide serves as an important research tool for investigating growth factor signalling cascades and receptor binding studies. Research laboratories studying muscle biology often evaluate IGF1-LR3’s effects on myoblast proliferation and myotube formation in cell culture systems. Additionally, researchers analyse its role in glucose metabolism pathways and protein synthesis regulation. The extended half-life properties make it suitable for longitudinal studies requiring sustained growth factor presence. Studies within our IGF-1 peptide collection demonstrate its versatility across multiple research protocols. Many laboratories combine IGF1-LR3 studies with investigations involving selective androgen receptor modulators to examine synergistic effects on cellular growth pathways. Comparative studies with other research peptides provide valuable insights into growth factor mechanisms.
Product Specifications
| Parameter | Specification |
|---|---|
| Purity | ≥98% (HPLC verified) |
| Molecular Weight | Verify with supplier |
| CAS Number | Verify with supplier |
| Storage | -20°C lyophilised, 2-8°C reconstituted |
| Stability | 36 months lyophilised powder |
| Reconstitution | Bacteriostatic water recommended |
Research Compliance Statement
IGF1-LR3 Pharmaqo is manufactured exclusively for in-vitro laboratory research purposes. This product is not intended for human consumption, therapeutic application, or diagnostic use. Researchers must maintain appropriate laboratory safety protocols and ensure compliance with institutional research guidelines. All studies should be conducted within controlled laboratory environments by qualified personnel. This peptide is supplied for scientific investigation only and requires proper handling procedures and storage conditions to maintain research integrity.
